Skip to main content

Table 3 NIH-CPSI questionnaire results

From: Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®)

 

Group A

Group B

Symptoms score (NIH-CPSI questionnaire 0–43) (±S.D.)

  

  Baseline

21.85 ± 5.23

22.56 ± 5.78

  2 months

12.00 ± 4.34

5.23 ± 2.76

  4 months

10.48 ± 4.14

4.11 ± 2.32

  6 months

13.26 ± 4.88

3.67 ± 1.98

Pain score (NIH-CPSI questionnaire 0–21) (±S.D.)

  

  Baseline

11.65 ± 3.23

12.00 ± 2.78

  2 months

6.20 ± 2.35

2.13 ± 1.90

  4 months

5.82 ± 2.10

1.65 ± 1.17

  6 months

8.06 ± 2.81

1.25 ± 0.99

Urinary score (NIH-CPSI questionnaire 0–10) (±S.D.)

  

  Baseline

4.65 ± 2.11

4.26 ± 2.28

  2 months

2.35 ± 1.35

1.34 ± 0.89

  4 months

2.10 ± 1.15

1.11 ± 0.89

  6 months

2.65 ± 1.44

1.01 ± 0.76

Symptoms (%)

  

  Baseline

76 (100)

77 (100)

  2 months

15 (19.7)

7 (9)

  4 months

18 (23.7)

7 (9)

  6 months

20 (26.3)

5 (6.5)

QoL (NIH-CPSI questionnaire 0–12) (±S.D.)

  

  Baseline

5.76 ± 2.44

5.66 ± 2.39

  2 months

2.89 ± 1.68

1.85 ± 1.00

  4 months

2.60 ± 1.43

1.66 ± 0.95

  6 months

3.09 ± 1.74

1.40 ± 0.94